Clinical
In short supply
TGA warns of a serious shortage of HRT patches, and their planned replacements, as well as some oral contraceptives Australia is facing a shortage of estradiol patches which will last …
Mixed decisions from scheduling committee
Ranitidine set to remain an S3 medicine, while TGA decides to downschedule migraine and acne treatments The Therapeutic Goods Administration (TGA) scheduling delegate has confirmed that the reflux treatment ranitidine …
Boost for minor ailment treatment
Running a national minor ailment scheme through community pharmacy is cost effective, and clinically effective, new research claims Researchers from the University of Technology Sydney conducted a randomised controlled trial …
Supply shutdown
Depression treatment no longer to be supplied in Australia Australian consumers and health professionals are being advised that phenelzine tablets will no longer being supplied, and stock is currently very …
Diabetes med cardio boost
A multinational study involving Australian researchers has found more evidence for cardiovascular benefits associated with the newest group of oral medications used to treat type 2 diabetes New research has …
Barriers and enablers to safe medication management
“The battle that we have as a credentialed pharmacist is the doctor is too terrified to stop medication, because if they have a heart attack or a stroke then they’re …
Up, up and away
Australian pharmacists have the knowledge to deliver travel health advice, research shows, justifying calls for pharmacy supply of vaccines and other health medicines A study, conducted by researchers from …
COVID-19: the pharmacist impact
Italy is one of the nations that has been most impacted by the COVID-19 pandemic. New data shows just how it has affected community pharmacists Since the beginning of …
Built-in flexibility
Government moves to temporarily ease PBS authority restrictions during pandemic crisis The Australian Government is implementing a temporary measure that allows flexibility around PBS restrictions for eligible PBS medicines to …
Emergency and ongoing contraception in the COVID-19 pandemic
In Australia you can expect increased demand of emergency contraception during the COVID-19 outbreak, write Dr Safeera Hussainy and Dr Kathleen McNamee Dr Safeera Hussainy, Adjunct Senior Lecturer and Chief …
‘There are very limited data to support its use.’
5 highlights from NPS MedicineWise’s new comprehensive update for health professionals on the use hydroxychloroquine for COVID-19 NPS MedicineWise has added a new article that reviews the latest evidence on …
‘Living’ guidelines go live
Pharmacists comprise part of the taskforce behind newly released guidelines updated in near real time, to help Australian clinicians deliver best care during COVID-19 crisis A coalition of peak Australian …